Finally, the authors showed that NOTUM inhibitor treatment reduced the clonal capacity of Apc-null intestinal cells and reduced the number of tumour lesions in an Apc-mutant-driven model of intestinal tumourigenesis at a 21-day timepoint [24]. This evidence concerns the gene APC and neoplasm.